Search alternatives:
significant processes » significant progress (Expand Search), significant promise (Expand Search), significant increases (Expand Search)
larger decrease » marked decrease (Expand Search)
processes using » processed using (Expand Search), process using (Expand Search), properties using (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 61 - 80 results of 68,884 for search '(( significantly ((lower decrease) OR (larger decrease)) ) OR ( significant processes using ))', query time: 0.60s Refine Results
  1. 61
    Demographic characteristics of study participants.

    Demographic characteristics of study participants. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01.

    Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 63
    Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01.

    Comparison of treatment effects between premolar extraction and mandibular third molar extraction groups. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 64
    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction.

    Intraoperative facial and intraoral photographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with premolar tooth extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction.

    Pretreatment facial, intraoral photographs, and radiographs of the case with mandibular third molar extraction. by Lijuan Liu (136685)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    This figure is the PRISMA used in synthesis of the systematic review.

    This figure is the PRISMA used in synthesis of the systematic review. by Aahan Arif (20189512)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 68
    qRT-PCR primers used in this study.

    qRT-PCR primers used in this study. by Tanaporn Wangsanut (10654935)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Keywords used in the screening process.

    Keywords used in the screening process. by Sharifah Maziah Syed Shamsuddin (20147953)

    Published 2024
    Save to List
    Saved in:
  10. 70
    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is).

    The results of KEGG enrichment analysis (Annotation: Circles represent each pathway, and the redder the color, the larger the circle, and the more important it is). by Lin Zhou (141050)

    Published 2023
    Save to List
    Saved in:
  11. 71
    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.

    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in... by Ranjeeta Adhikari (9905958)

    Published 2023
    Save to List
    Saved in:
  12. 72
    CBP per cumulative year for daratumumab and pembrolizumab per vial.

    CBP per cumulative year for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 73
    S4 Fig -

    S4 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 74
    S1 Fig -

    S1 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 75
    S5 Fig -

    S5 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 76
    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial.

    Scenario analysis for pembrolizumab using a cumulative cost-based price per year per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 77
    S3 Fig -

    S3 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 78
    S6 Fig -

    S6 Fig - by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 79
    CBP per cumulative indication for daratumumab and pembrolizumab per vial.

    CBP per cumulative indication for daratumumab and pembrolizumab per vial. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 80
    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation.

    Inputs utilized in base-case and scenario analysis for daratumumab and pembrolizumab, both unadjusted and adjusted for PPP and inflation. by R. J. S. D. Heine (17889199)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: